The two antibodies, casirivimab and imdevimab, should be given to people infected with COVID-19 who are at highest risk of hospitalization or who have weak immune systems.
Pricey COVID-19 antibody treatment gets WHO approval
© The Crystal Eyes
The two antibodies, casirivimab and imdevimab, should be given to people infected with COVID-19 who are at highest risk of hospitalization or who have weak immune systems.
© The Crystal Eyes